Why is Moderna Inc important to traders?
Learn all about what Moderna is, its share trading hours, and how to trade Moderna share CFDs with Capital.com
Learn more about Moderna IncTrade Moderna Inc - MRNA CFD
Add to favourite- Summary
- Historical Data
Trading сonditions
| Spread | 0.15 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.024124% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001901% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 0.6 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
Key Stats
| Prev. Close | 38.2 |
| Open | 38.17 |
| 1-Year Change | -50.08% |
| Day's Range | 38.05 - 42.07 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Nov 22, 2024 | 41.08 | 2.81 | 7.34% | 38.27 | 42.33 | 37.63 |
| Nov 21, 2024 | 38.27 | 1.42 | 3.85% | 36.85 | 38.72 | 35.91 |
| Nov 20, 2024 | 36.85 | -0.38 | -1.02% | 37.23 | 38.17 | 36.36 |
| Nov 19, 2024 | 37.23 | -2.20 | -5.58% | 39.43 | 39.63 | 36.95 |
| Nov 18, 2024 | 39.45 | 2.25 | 6.05% | 37.20 | 39.70 | 36.95 |
| Nov 15, 2024 | 36.86 | -2.47 | -6.28% | 39.33 | 39.50 | 35.75 |
| Nov 14, 2024 | 39.39 | -2.56 | -6.10% | 41.95 | 42.32 | 38.65 |
| Nov 13, 2024 | 42.00 | -1.45 | -3.34% | 43.45 | 43.67 | 41.65 |
| Nov 12, 2024 | 43.43 | 0.80 | 1.88% | 42.63 | 44.03 | 41.50 |
| Nov 11, 2024 | 42.54 | -4.16 | -8.91% | 46.70 | 47.09 | 42.20 |
| Nov 8, 2024 | 46.80 | -3.30 | -6.59% | 50.10 | 50.83 | 46.52 |
| Nov 7, 2024 | 50.10 | -1.68 | -3.24% | 51.78 | 58.45 | 49.88 |
| Nov 6, 2024 | 51.65 | -1.48 | -2.79% | 53.13 | 54.96 | 49.53 |
| Nov 5, 2024 | 52.89 | -0.82 | -1.53% | 53.71 | 54.19 | 52.03 |
| Nov 4, 2024 | 53.71 | -0.44 | -0.81% | 54.15 | 55.56 | 53.36 |
| Nov 1, 2024 | 54.45 | 0.20 | 0.37% | 54.25 | 55.29 | 53.83 |
| Oct 31, 2024 | 53.84 | -0.19 | -0.35% | 54.03 | 54.63 | 52.88 |
| Oct 30, 2024 | 53.95 | -0.93 | -1.69% | 54.88 | 55.51 | 53.44 |
| Oct 29, 2024 | 54.95 | 0.20 | 0.37% | 54.75 | 57.60 | 54.75 |
| Oct 28, 2024 | 54.77 | 1.75 | 3.30% | 53.02 | 55.69 | 52.95 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
Trade commission
0
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
Leverage
20:1
- 20
- 100
- 500
- 1000
- 10000
Investment
Trade size (Leverage x Investement):
Open
Close
Short Long
Moderna, Inc. Company profile
Get all the information you need on the Moderna stock price today with Capital.com’s comprehensive chart.
Moderna (MRNA) is a North American clinical-stage biotechnology company. Headquartered in Cambridge, Massachusetts, it specialises in drug discovery and development, as well as vaccine technologies based on messenger RNA (mRNA). The company is working on therapeutics and vaccines for infectious, autoimmune, immuno-oncology and cardiovascular diseases.
Moderna has a number of strategic partnerships with industry-leading names, such as Vertex Pharmaceuticals (VRTX), AstraZeneca (AZN) and Merck & Co (MRK). In 2020, it also worked with Lonza Group (LONN) and Catalent (CTLT) to manufacture its Covid-19 vaccine candidate mRNA-1273. At the end of 2020, the company had 12 programmes in clinical trials and a total of 23 development candidates.
Moderna shares are listed on the Nasdaq Stock Market under the ticker symbol MRNA. The company is a constituent of the US Tech 100 Index.
Stay up-to-date with the latest market news and watch the Moderna share price live at Capital.com.
The company was founded in 2010 as Moderna Therapeutics, with the goal of commercialising the research of stem-cell biologist Derrick Rossi. Apart from Rossi, Moderna’s co-founders were Noubar Afeyan, Robert Langer and Kenneth Chien. In August 2018, the company’s name was changed to Moderna.
In November 2020, Moderna’s Covid-19 vaccine candidate, mRNA-1273, showed preliminary evidence of 94.1 per cent efficacy in preventing the disease in a Phase 3 trial. The results led to its submission for emergency use authorisation in the US, Canada and Europe.
In late November, the EU made a deal with Moderna for up to 160 million doses of its vaccine. In December, the US government exercised its option to buy an additional 100 million doses of Moderna’s mRNA-1273, bringing the confirmed order commitment to 200 million doses.
With Capital.com’s Moderna share price chart, you can not only quickly view the current MRNA stock quote, but also trace the company’s share value in historic terms.
Moderna’s long-awaited initial public offering (IPO) happened in December 2018, with the firm selling 26.3 million shares priced at $23 each. At the time, it was the biggest biotech IPO ever. Moderna raised over $600m, valuing the company at $7.5bn (£5.6bn, €6.2bn).
In 2020, MRNA stock has been one of the US market’s best performers. This was due to rising investor enthusiasm over the company’s promising Covid-19 vaccine candidate. After opening the year at $19.57, the MRNA share price was on a hike, peaking at $94.85 in mid July. Within a month, it had dropped to $54.23, but then the stock gained another upside momentum, with its price surging past $100 on November 16. On December 8, the stock closed the trading day at $169.86, representing a year-to-date gain of nearly 770 per cent.
You can go long or short on the company’s shares and trace all the latest ups and downs of the Moderna Inc. stock price using Capital.com’s proprietary trading platform.
| Industry: | Biotechnology & Medical Research (NEC) |
200 Technology Sq
CAMBRIDGE
MASSACHUSETTS 02139-3578
US
News
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
15:17, 18 November 2024
Shiba Inu coin price prediction 2030: could Shiba Inu coin reach $1? Third party price target
Can Shiba Inu reinvent itself to become a worthy long-term investment?
08:36, 15 November 2024
Trump trades charge as Bitcoin hits $US80,000
Bitcoin hits $80,000 amid expectations of fiscal stimulus, lower regulatory risks, and resilient US economy.
10:48, 13 November 2024
Australian jobs data expected to point to solid labour market conditions
Australian labour market and wage data to reveal job growth resilience, shaping RBA rate cut expectations and impacting AUD amidst global economic shifts.
10:16, 13 November 2024
FOMC cuts interest rates as expected and sticks to its line on future policy
The FOMC cut interest rates by 25 basis points at its November meeting, aligning with expectations. Wall Street hit record highs following the decision, with tech stocks leading the rally. Markets are pricing in a probable December cut amid resilient economic indicators.
13:33, 8 November 2024
FOMC and BOE preview: further rate cuts expected
Both the Federal Reserve and the Bank of England are expected to cut rates further when they meet later this week.
14:14, 5 November 2024
RBA meeting preview: No change to policy expected as inflation fight continues
The Reserve Bank of Australia is expected to keep its cash rate on hold at 4.35% when it announces its policy decision at 2.30PM on the 5th of November, 2024. Despite ongoing evidence of soft demand, upside risks to inflation are likely to remain the central bank’s primary concern.
13:35, 4 November 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com